IDNA vs. IZRL ETF Comparison
Comparison of iShares Genomics Immunology and Healthcare ETF (IDNA) to ARK Israel Innovative Technology ETF (IZRL)
IDNA
iShares Genomics Immunology and Healthcare ETF
IDNA Description
The investment seeks to track the investment results of the NYSE FactSet Global Genomics and Immuno Biopharma Index. The fund generally will invest at least 90% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 10% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. It is non-diversified.
Grade (RS Rating)
Last Trade
$24.09
Average Daily Volume
26,896
40
IZRL
ARK Israel Innovative Technology ETF
IZRL Description
The ARK Israel Innovative Technology ETF (IZRL) seeks to provide investment results that closely correspond, before fees and expenses, to the performance of the ARK Israeli Innovation Index, which is designed to track the price movements of exchange-listed Israeli companies whose main business operations are causing disruptive innovation in the areas of genomics, health care, biotechnology, industrials, manufacturing, the Internet or information technology. The Index includes equity securities and depositary receipts of exchange listed companies that are incorporated and/or domiciled in Israel (‘‘Israeli Companies’’) and are included in one of the following economic sectors as defined by FactSet Research Systems: (i) health technology, (ii) communications, (iii) technology services, (iv) electronic technology, (v) consumer services, or (vi) producer manufacturing.Grade (RS Rating)
Last Trade
$20.08
Average Daily Volume
18,406
24
Performance
| Period | IDNA | IZRL |
|---|---|---|
| 30 Days | 12.07% | 7.32% |
| 60 Days | 3.31% | -3.76% |
| 90 Days | 3.37% | -3.21% |
| 12 Months | -0.61% | 14.04% |
0 Overlapping Holdings
| Symbol | Grade | Weight in IDNA | Weight in IZRL | Overlap |
|---|
IDNA Overweight 40 Positions Relative to IZRL
| Symbol | Grade | Weight | |
|---|---|---|---|
| MRNA | C | 6.33% | |
| RVMD | C | 5.69% | |
| SRPT | C | 5.38% | |
| MRK | B | 4.45% | |
| REGN | C | 4.29% | |
| INCY | F | 3.74% | |
| EXEL | F | 3.37% | |
| BNTX | C | 3.26% | |
| BGNE | C | 3.14% | |
| GILD | F | 3.05% | |
| TWST | B | 2.96% | |
| SWTX | D | 2.53% | |
| IOVA | D | 2.48% | |
| ACLX | F | 2.28% | |
| BEAM | F | 2.07% | |
| GERN | C | 2.05% | |
| NVAX | B | 2.0% | |
| DVAX | F | 1.78% | |
| LGND | B | 1.73% | |
| BCRX | D | 1.55% | |
| DCPH | A | 1.49% | |
| BPMC | B | 1.34% | |
| DNA | F | 1.17% | |
| FDMT | D | 1.1% | |
| VIR | F | 1.09% | |
| IBRX | C | 1.08% | |
| RCUS | F | 1.01% | |
| ABCL | F | 0.93% | |
| CRSP | F | 0.91% | |
| ARCT | F | 0.88% | |
| NRIX | D | 0.85% | |
| EDIT | F | 0.54% | |
| VALN | F | 0.53% | |
| NTLA | F | 0.49% | |
| OABI | D | 0.49% | |
| CVAC | F | 0.37% | |
| XNCR | C | 0.31% | |
| MGNX | F | 0.3% | |
| CRBU | F | 0.27% | |
| QURE | F | 0.25% |
IDNA Underweight 24 Positions Relative to IZRL
| Symbol | Grade | Weight | |
|---|---|---|---|
| PLTK | C | -2.56% | |
| FVRR | C | -2.52% | |
| TEVA | A | -2.52% | |
| RSKD | B | -2.49% | |
| RDWR | C | -2.44% | |
| MNDY | F | -2.36% | |
| CGNT | C | -2.3% | |
| NNOX | C | -2.3% | |
| SPNS | B | -2.27% | |
| MGIC | B | -2.25% | |
| WIX | D | -2.21% | |
| CLBT | D | -2.19% | |
| ITRN | C | -2.17% | |
| INMD | F | -2.13% | |
| WKME | F | -2.08% | |
| CYBR | D | -2.04% | |
| SMWB | D | -2.0% | |
| TARO | C | -1.98% | |
| NICE | D | -1.96% | |
| SSYS | F | -1.94% | |
| URGN | F | -1.91% | |
| CHKP | D | -1.86% | |
| AUDC | F | -1.86% | |
| FROG | D | -1.77% |
IDNA: Top Represented Industries & Keywords
IZRL: Top Represented Industries & Keywords
Compare ETFs
